The current valuation score of Longeveron Inc is 7.85, ranking 184 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.64, which is -1179.69% below the recent high of 6.86 and -664.05% above the recent low of -4.85.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.